Mir A. Imran - 21 Jul 2026 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: RANI
Reported as of: 21 Jul 2026
Net transaction value: +$24,840
SEC form: 4
Accepted by SEC: 23 Jul 2026, 16:10:06 UTC
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Mir A Imran

Key filing fact

Mir A. Imran filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 23 Jul 2026.

Key facts

This page summarizes Mir A. Imran's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Jul 2026, 16:10.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: +$24,840.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001031686 Primary reporting owner

IMRAN MIR A

Relationship: Director, 10%+ Owner
Address: C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE
Signature: /s/ Mir A Imran
Signature date: 23 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RANI transaction

Class A Common Stock

Purchase

Transaction value: $24,840
Shares: +36,000
Change %: +1.7%
Price: $0.6900
Shares after: 2,119,334
Date: 21 Jul 2026
Ownership: Direct
Footnotes: F1

RANI holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 74,139
Date: 21 Jul 2026
Ownership: See footnote
Footnotes: F2

RANI holding

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,660,053
Date: 21 Jul 2026
Ownership: See footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.688 to $0.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Footnote F3

The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.